Manulife (Manufacturers Life Insurance)
ADVM

Manulife (Manufacturers Life Insurance)’s Adverum Biotechnologies ADVM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,359
Closed -$188K – 3141
2021
Q2 		$188K Buy
5,359
+187
+4% +$10.1K ﹤0.01% 3137
2021
Q1 		$510K Sell
5,172
-182
-3% -$21.9K ﹤0.01% 2258
2020
Q4 		$580K Buy
5,354
+401
+8% +$49.6K ﹤0.01% 2111
2020
Q3 		$510K Buy
4,953
+596
+14% +$89.3K ﹤0.01% 1990
2020
Q2 		$901K Buy
4,357
+439
+11% +$77.8K ﹤0.01% 1666
2020
Q1 		$383K Buy
3,918
+612
+19% +$71.4K ﹤0.01% 1953
2019
Q4 		$381K Sell
3,306
-95
-3% -$8.37K ﹤0.01% 2201
2019
Q3 		$185K Buy
3,401
+53
+2% +$5.97K ﹤0.01% 2631
2019
Q2 		$398K Sell
3,348
-458
-12% -$37.9K ﹤0.01% 2184
2019
Q1 		$199K Buy
3,806
+192
+5% +$7.76K ﹤0.01% 2435
2018
Q4 		$114K Sell
3,614
-120
-3% -$4.88K ﹤0.01% 2424
2018
Q3 		$226K Sell
3,734
-624
-14% -$35K ﹤0.01% 2696
2018
Q2 		$232K Buy
4,358
+4,234
+3,415% +$255K ﹤0.01% 3014
2018
Q1 		$7K Sell
124
-126
-50% -$7.84K ﹤0.01% 4011
2017
Q4 		$9K Buy
250
+209
+510% +$6.88K ﹤0.01% 3984
2017
Q3 		$1K Sell
41
-55
-57% -$1.53K ﹤0.01% 4144
2017
Q2 		$2K Buy
96
+31
+48% +$848 ﹤0.01% 4098
2017
Q1 		$2K Hold
65
– – ﹤0.01% 3925
2016
Q4 		$2K Hold
65
– – ﹤0.01% 4088
2016
Q3 		$3K Hold
65
– – ﹤0.01% 3984
2016
Q2 		$2K Sell
65
-1,415
-96% -$63.9K ﹤0.01% 3974
2016
Q1 		$74K Buy
1,480
+105
+8% +$5.86K ﹤0.01% 3173
2015
Q4 		$131 Buy
1,375
+58
+4% +$5.1K ﹤0.01% 2960
2015
Q3 		$109 Buy
1,317
+40
+3% +$5.11K ﹤0.01% 3085
2015
Q2 		$207 Buy
1,277
+716
+128% +$242K ﹤0.01% 2818
2015
Q1 		$227 Buy
561
+68
+14% +$28.7K ﹤0.01% 2638
2014
Q4 		$266 Buy
+493
New +$190K ﹤0.01% 2445

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ADVM Position: Q3 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Adverum Biotechnologies (ADVM) in Q3 2021, closing a stake of 5,359 shares — an estimated $188K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ADVM in Q4 2014 and held it in 27 quarters. The position peaked at $901K in Q2 2020. 110 funds tracked by Wall St. Rank hold ADVM as of Q3 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Adverum Biotechnologies position as of Q3 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 5,359 Adverum Biotechnologies shares in Q3 2021, an estimated $188K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 27 quarters.
  • Manulife (Manufacturers Life Insurance)'s Adverum Biotechnologies position peaked at $901K in Q2 2020.
  • 110 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.